Local and distant histopathological effects of unilateral amyloid-beta 25-35 injections into the amygdala of young F344 rats - PubMed (original) (raw)
Local and distant histopathological effects of unilateral amyloid-beta 25-35 injections into the amygdala of young F344 rats
E M Sigurdsson et al. Neurobiol Aging. 1996 Nov-Dec.
Abstract
To determine if amyloid-beta (A beta) induces tau-immunoreactivity (IR) and reactive astrocytosis in vivo, we injected A beta 25-35 (5.0 nmol) into the right amygdala of rats. At 8 days postinjection, the peptide induced tau-2 IR in neuronal cell bodies and processes ipsilaterally in the amygdala, cingulate cortex, and hippocampus. At 32 days postinjection, the intensity of tau-2 IR was greater than at 8 days in the amygdala and hippocampus, but not in the cingulate cortex. Induction of Alz-50 IR also was progressive but the morphology and distribution was different from tau-2 IR. Beaded fibers with occasional neuronal perikarya were visualized with Alz-50, and the IR was primarily observed in the ipsilateral amygdala. In addition, amygdaloid injections of A beta 25-35 induced reactive astrocytosis, particularly in the ipsilateral hippocampus at 32 days postoperatively. To our knowledge, this is the first study to show that in vivo injections of A beta 25-35 induce progressive transsynaptic cytoskeletal and astrogliotic reactions, that gradually spread from the area of injection to brain regions that have prominent efferent connections with that area. These findings also suggest a direct association between plaque and tangle formation in Alzheimer's disease.
Similar articles
- Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects.
Sigurdsson EM, Lee JM, Dong XW, Hejna MJ, Lorens SA. Sigurdsson EM, et al. Neurobiol Aging. 1997 Nov-Dec;18(6):591-608. doi: 10.1016/s0197-4580(97)00154-1. Neurobiol Aging. 1997. PMID: 9461057 - Laterality in the histological effects of injections of amyloid-beta 25-35 into the amygdala of young Fischer rats.
Sigurdsson EM, Lee JM, Dong XW, Hejna MJ, Lorens SA. Sigurdsson EM, et al. J Neuropathol Exp Neurol. 1997 Jun;56(6):714-25. J Neuropathol Exp Neurol. 1997. PMID: 9184662 - Neurotoxicity and oxidative damage of beta amyloid 1-42 versus beta amyloid 1-40 in the mouse cerebral cortex.
Klein AM, Kowall NW, Ferrante RJ. Klein AM, et al. Ann N Y Acad Sci. 1999;893:314-20. doi: 10.1111/j.1749-6632.1999.tb07845.x. Ann N Y Acad Sci. 1999. PMID: 10672257 - Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain.
Dudas B, Cornelli U, Lee JM, Hejna MJ, Walzer M, Lorens SA, Mervis RF, Fareed J, Hanin I. Dudas B, et al. Neurobiol Aging. 2002 Jan-Feb;23(1):97-104. doi: 10.1016/s0197-4580(01)00255-x. Neurobiol Aging. 2002. PMID: 11755024 - In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment.
Kowall NW, McKee AC, Yankner BA, Beal MF. Kowall NW, et al. Neurobiol Aging. 1992 Sep-Oct;13(5):537-42. doi: 10.1016/0197-4580(92)90053-z. Neurobiol Aging. 1992. PMID: 1461341
Cited by
- Antibody response and plasma Abeta1-40 levels in young Microcebus murinus primates immunized with Abeta1-42 and its derivatives.
Trouche SG, Asuni A, Rouland S, Wisniewski T, Frangione B, Verdier JM, Sigurdsson EM, Mestre-Francés N. Trouche SG, et al. Vaccine. 2009 Feb 11;27(7):957-64. doi: 10.1016/j.vaccine.2008.12.012. Epub 2008 Dec 27. Vaccine. 2009. PMID: 19114076 Free PMC article. - Immunotherapy for tauopathies.
Gu J, Sigurdsson EM. Gu J, et al. J Mol Neurosci. 2011 Nov;45(3):690-5. doi: 10.1007/s12031-011-9576-5. Epub 2011 Jul 8. J Mol Neurosci. 2011. PMID: 21739165 Free PMC article. Review. - Amyloid peptide toxicity and microtubule-stabilizing drugs.
Michaelis ML, Chen Y, Hill S, Reiff E, Georg G, Rice A, Audus K. Michaelis ML, et al. J Mol Neurosci. 2002 Aug-Oct;19(1-2):101-5. doi: 10.1007/s12031-002-0018-2. J Mol Neurosci. 2002. PMID: 12212764 - Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model.
Boutajangout A, Quartermain D, Sigurdsson EM. Boutajangout A, et al. J Neurosci. 2010 Dec 8;30(49):16559-66. doi: 10.1523/JNEUROSCI.4363-10.2010. J Neurosci. 2010. PMID: 21147995 Free PMC article. - Two novel Tau antibodies targeting the 396/404 region are primarily taken up by neurons and reduce Tau protein pathology.
Gu J, Congdon EE, Sigurdsson EM. Gu J, et al. J Biol Chem. 2013 Nov 15;288(46):33081-95. doi: 10.1074/jbc.M113.494922. Epub 2013 Oct 2. J Biol Chem. 2013. PMID: 24089520 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources